Bioscience

Brigham and Women’s selects ValiMed by Tucson-based CDEX

September 1, 2009

By Flinn Foundation

[Source: CNN Money] – CDEX Inc. announces that Brigham and Women’s Hospital (Boston, MA) has selected the CDEX ValiMed(TM) Medication Safety System as part of its Medication Safety Program. Studies worldwide continue to show that mistakes in the compounding of high-risk medications occur and result in substantial harm to patients and economic loss to hospitals. In an 18-month University of Michigan Health System study, ValiMed identified 5 major medical errors. ValiMed is used to validate the compounding of high-risk liquid medications in a pharmacy setting and also as a verification program to reduce the diversion of return narcotics in hospitals and other healthcare facilities.

For more information: Brigham and Women’s Hospital Selects ValiMed(TM) by CDEX as Part of Its Medication Safety Program